DHX Company Co., Ltd. (DHX Company) Aktie

DHX Company Co., Ltd. engages in biomedical and distribution businesses in South Korea. The company offers Microbiome to treat intractable skin diseases; REJURUB; and AI digital brain diagnostic device. It also purchases and distributes IT components, including graphics cards, DRAM, CPUs, high-capacity storage, and multi-purpose displays; import and distribution of cosmetics; f and b distribution; and meditech distribution. In addition, the company is involved in manufacture and distribution of computers and peripherals; investment and asset management; and commodity brokerage business. The company was formerly known as SU-Holdings Co.,Ltd. and changed its name to DHX Company Co., Ltd. in December 2024. DHX Company Co., Ltd. was founded in 1979 and is headquartered in Seoul, South Korea.